Correlation Between Antisense Therapeutics and Aion Therapeutic
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and Aion Therapeutic, you can compare the effects of market volatilities on Antisense Therapeutics and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Aion Therapeutic.
Diversification Opportunities for Antisense Therapeutics and Aion Therapeutic
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Antisense and Aion is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Aion Therapeutic go up and down completely randomly.
Pair Corralation between Antisense Therapeutics and Aion Therapeutic
Assuming the 90 days horizon Antisense Therapeutics Limited is expected to under-perform the Aion Therapeutic. But the pink sheet apears to be less risky and, when comparing its historical volatility, Antisense Therapeutics Limited is 3.23 times less risky than Aion Therapeutic. The pink sheet trades about -0.45 of its potential returns per unit of risk. The Aion Therapeutic is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 0.38 in Aion Therapeutic on October 23, 2024 and sell it today you would earn a total of 0.72 from holding Aion Therapeutic or generate 189.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 26.32% |
| Values | Daily Returns |
Antisense Therapeutics Limited vs. Aion Therapeutic
Performance |
| Timeline |
| Antisense Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aion Therapeutic |
Antisense Therapeutics and Aion Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Antisense Therapeutics and Aion Therapeutic
The main advantage of trading using opposite Antisense Therapeutics and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.| Antisense Therapeutics vs. Amexdrug | Antisense Therapeutics vs. Aion Therapeutic | Antisense Therapeutics vs. Alterola Biotech | Antisense Therapeutics vs. The BC Bud |
| Aion Therapeutic vs. Amexdrug | Aion Therapeutic vs. Alterola Biotech | Aion Therapeutic vs. HLS Therapeutics | Aion Therapeutic vs. Cannara Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |